Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-033851
Filing Date
2019-06-04
Accepted
2019-06-04 17:19:34
Documents
1
Period of Report
2019-05-31

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5434
  Complete submission text file 0001104659-19-033851.txt   7051
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 142 WEST 57TH STREET NEW YORK NY 10019
Business Address
LAZARUS ROCHELLE B (Reporting) CIK: 0001082206 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0201
Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 19877682
SIC: 5621 Retail-Women's Clothing Stores